Liquidia Corporation (LQDA): Billionaire Tom Steyer Admires This Pharma Stock

Liquidia Corporation (NASDAQ:LQDA) archetypal appeared successful the 13F portfolio of Farallon Capital successful the 2nd 4th of 2020. Back then, this presumption comprised 1.8 cardinal shares. The money sold disconnected this involvement earlier the extremity of the year. A caller presumption successful the banal was past opened successful the archetypal 4th of 2024. This consisted of 2 cardinal shares. Since then, the money has added to this holding. Filings for the 4th fourth of 2025 amusement that the money owned 8.6 cardinal shares successful the firm, up somewhat compared to filings for the erstwhile quarter. Liquidia is simply a biopharmaceutical institution that develops, manufactures, and commercializes assorted products for uncommon cardiopulmonary diseases successful the United States.

Photo by Arturo Añez connected Unsplash

Liquidia Corporation (NASDAQ:LQDA) is viewed arsenic a top-tier takeout campaigner and a disruptive unit successful the pulmonary hypertension market. While the institution faces ongoing litigation from its main rival, United Therapeutics, elite investors are focused connected Liquidia’s modulation into a profitable, billion-dollar franchise. The superior operator for organization involvement is the accelerated adoption of YUTREPIA, Liquidia’s dry-powder treprostinil. In its Q4 2025 earnings, the steadfast reported $90.1 cardinal successful merchandise income for the quarter, a 74% sequential summation from Q3. Since its afloat motorboat successful June 2025, Liquidia has captured a 17% stock of the inhaled treprostinil market. Hedge funds are betting connected this inclination continuing arsenic the institution expands its income unit to people the implicit 860 progressive prescribers it has already engaged. CEO Roger Jeffs confirmed a wide way to becoming a $1 cardinal franchise by 2027.

While we admit the imaginable of LQDA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best Defensive Stocks to Invest In Now and 14 Best Low Risk High Growth Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey connected Google News.